Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod

Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod
aliu
Mon, 03/08/2021 – 07:59